J2KBIO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28,500 KRW | -9.81% |
|
+12.43% | 0.00% |
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 |
|---|---|
| Net sales 1 | 28,472 |
| EBITDA 1 | 6,241 |
| EBIT 1 | 5,607 |
| Operating Margin | 19.69% |
| Earnings before Tax (EBT) 1 | 5,572 |
| Net income 1 | 4,844 |
| Net margin | 17.01% |
| EPS 2 | 978.3 |
| Free Cash Flow 1 | -752.5 |
| FCF margin | -2.64% |
| FCF Conversion (EBITDA) | - |
| FCF Conversion (Net income) | - |
| Dividend per Share 2 | 4,000 |
| Announcement Date | 27/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 |
|---|---|
| Net Debt 1 | - |
| Net Cash position 1 | 3,156 |
| Leverage (Debt/EBITDA) | - |
| Free Cash Flow 1 | -752 |
| ROE (net income / shareholders' equity) | 33.4% |
| ROA (Net income/ Total Assets) | 17.7% |
| Assets 1 | 27,389 |
| Book Value Per Share 2 | 3,533 |
| Cash Flow per Share 2 | 777.0 |
| Capex 1 | 1,369 |
| Capex / Sales | 4.81% |
| Announcement Date | 27/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 128M | |
| -0.82% | 90.85B | |
| -0.92% | 39.02B | |
| -9.57% | 33.46B | |
| -17.98% | 14.51B | |
| -6.74% | 13.22B | |
| -9.76% | 11.65B | |
| -47.31% | 10.57B | |
| +6.52% | 9.23B | |
| +137.06% | 7.71B |
- Stock Market
- Equities
- A420570 Stock
- Financials J2KBIO Co., Ltd.
